Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to Gynesonics
WOODSIDE, Calif., Jan. 12, 2021 – Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior secured term loan of $50 million to Gynesonics, a healthcare company focused on advancing women’s health by developing […]
Read MoreDr. Scott Chudnoff, Chief of Gynecology at Stamford Health System in Stamford, Connecticut, is the lead author of the SONATA Trial 12 month results published in the January 2019 issue of Obstetrics and Gynecology.
Read MoreDr. David Levine is a gynecologist with Mercy Hospital, St. Louis who discusses traditional treatments for uterine fibroids and the SONATA Study offering the latest technology. Mercy Hospital is the only clinical study site in the state amongst 22 other US sites.
Read MoreDr. Nicole Morin, Dr. Minda Green, Dr. Dipak Delvadia, and Marisol Burgos watch the computer screen during performance of a new procedure using ultrasound and radio frequency for a trans-cervical uterine fibroid ablation at Hahnemann Hospital in Philadelphia on Monday, April 25, 2016. The procedure was the second of its kind performed in Philadelphia.
Read MoreDr. Vadim Morozov, assistant professor of obstetrics and gynecology at the University of Maryland Medical Center, is testing the Sonata System, which is used to image and treat fibroids without surgery.
Read MoreYou deliver heat energy directly to the fibroids, which can dry and shrink them,” said Dr. Jay Hudgens, assistant professor of obstetrics and gynecology and lead investigator for the UMMC study site.
Read MoreIt may be because it’s more common the older we get, and fibroids tend to be more troublesome closer to menopause,” speculates Dr. Linda S. Mihalov, a general gynecologist specializing in minimally invasive surgery, at Virginia Mason Medical Center.
Read MoreA minimally invasive device developed by Gynesonics of Redwood City, CA, to treat uterine fibroids by integrating ultrasound imaging and radio frequency ablation has been tested in Germany and could be an alternative to controversial power morcellators.
Read More- « Previous
- 1
- 2
- 3
- 4